ENHO and diabetes mellitus: Adropin has emerged as a crucial regulator of metabolic, cardiovascular, and cerebrovascular physiology, demonstrating protective effects across a wide range of conditions, including metabolic syndrome, diabetes, cardiovascular diseases, and stroke.